Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OPTH · against 1,336 other Healthcare companies
Ranked #921 of 1,337 · scores higher than 30% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including OPTH · Click a bar to see the companies
Mainly because of its EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | OPTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | Not reported | 1.5% | — | — | 30% |
| EBITDA yieldHigher is better · 1,357 reported | -45.4% | 4.2% | 5% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -30.9% | -1.0% | 9% | 20% | |
| Book yieldHigher is better · 1,306 reported | Not reported | 37.9% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score